Skip to main content

Codiak BioSciences, Inc.

CDAKInactive ticker
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001659352

No open-market purchases or sales by Codiak BioSciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

This ticker is no longer on the SEC's list of tickers: the company may have been delisted, or the ticker has changed.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Codiak BioSciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Codiak BioSciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Codiak BioSciences, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Howze YalondaSee Remarks7,458Mar 30, 20230
Sathyanarayanan SriramChief Scientific Officer0Mar 30, 20230
Konstantinov KonstantinChief Technology Officer0Mar 30, 20230
Bain LindaChief Financial Officer0Mar 30, 20230
Barna NicoleSee Remarks4,849Mar 30, 20230
Williams Douglas EPresident & CEO7,655Mar 30, 20230
Cooney Charles LDirector8,750Feb 21, 20230
Melas Kyriazi TheoDirector15,350Feb 21, 20230
Gillis StevenDirector8,750Feb 21, 20230
Bernstein KarenDirector8,750IndirectFeb 21, 20230
Haddock JasonDirector8,750Feb 21, 20230
Mauro David JChief Medical Officer–Jan 26, 20230
Afeyan Noubar10% Owner1,188,920IndirectSep 16, 20220
Flagship Ventures Fund V, L.P.10% Owner1,188,920IndirectSep 16, 20220
Flagship Ventures Fund V General Partner LLC10% Owner1,188,920IndirectSep 16, 20220
Flagship V VentureLabs Rx Fund, L.P.10% Owner1,188,920IndirectSep 16, 20220
Crandell Keith10% Owner8,854,098IndirectSep 15, 20220
Nelsen Robert10% Owner8,854,098IndirectSep 15, 20220
Bybee Clinton10% Owner8,854,098IndirectSep 15, 20220
ARCH Venture Fund VIII, L.P.10% Owner8,854,098IndirectSep 15, 20220
ARCH Venture Partners VIII, LLC10% Owner8,854,098IndirectSep 15, 20220
ARCH Venture Partners VIII, L.P.10% Owner8,854,098IndirectSep 15, 20220
ARCH Venture Fund VIII Overage, L.P.10% Owner8,854,098IndirectSep 15, 20220
Pandite Arundathy N.Director–Jun 21, 20220
Eggimann Anne-VirginieDirector–Jun 21, 20220
Brudnick RichardSee Remarks–Feb 18, 20220
Sorensen BennySee Remarks0Sep 28, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 30, 2023 (view filing)6:01 PM ETMar 30Same dayHowze YalondaSee RemarksSSale−1.63K$0.1955−$318.27−17.9%7.46K after
Mar 30, 2023 (view filing)5:19 PM ETMar 291 daySathyanarayanan SriramChief Scientific OfficerSSale−11.8K$0.1652−$1.94K−100.0%0 after
Mar 30, 2023 (view filing)5:13 PM ETMar 282 daysKonstantinov KonstantinChief Technology OfficerSSale−9.36K$0.2001−$1.87K−100.0%0 after2 lots
Mar 30, 2023 (view filing)5:13 PM ETMar 282 daysBain LindaChief Financial OfficerSSale−13.4K$0.1693−$2.27K−100.0%0 after
Mar 30, 2023 (view filing)5:12 PM ETMar 291 dayBarna NicoleSee RemarksSSale−7.30K$0.1653−$1.21K−60.1%4.85K after2 lots
Mar 30, 2023 (view filing)5:12 PM ETMar 282 daysWilliams Douglas EPresident & CEOSSale−41.7K$0.18−$7.50K−84.5%7.66K after
Feb 21, 2023 (view filing)Aug 17, 2022-Feb 17, 2023188 daysLateBain LindaChief Financial OfficerSSale−4.93K$1.37−$6.74K−26.9%13.4K after2 lots
Feb 21, 2023 (view filing)Aug 17, 2022-Feb 17, 2023188 daysLateKonstantinov KonstantinChief Technology OfficerSSale−2.70K$1.38−$3.71K−26.6%7.43K after2 lots
Feb 21, 2023 (view filing)Aug 17, 2022-Feb 17, 2023188 daysLateWilliams Douglas EPresident & CEOSSale−14.8K$1.37−$20.2K−23.1%49.3K after2 lots
Feb 21, 2023 (view filing)Aug 17, 2022-Feb 17, 2023188 daysLateSathyanarayanan SriramChief Scientific OfficerSSale−4.69K$1.38−$6.47K−28.5%11.8K after2 lots
Feb 21, 2023 (view filing)Aug 17, 2022-Feb 17, 2023188 daysLateBarna NicoleSee RemarksSSale−2.26K$1.30−$2.93K−15.7%12.2K after2 lots
Feb 21, 2023 (view filing)Aug 17, 2022-Feb 17, 2023188 daysLateHowze YalondaSee RemarksSSale−3.12K$1.38−$4.29K−25.5%9.09K after2 lots
Jan 23, 2023 (view filing)Jan 203 daysBain LindaChief Financial OfficerSSale−1.88K$0.58−$1.09K−37.6%3.12K after
Jan 23, 2023 (view filing)Jan 203 daysKonstantinov KonstantinChief Technology OfficerSSale−1.07K$0.58−$620.02−38.2%1.73K after
Jan 23, 2023 (view filing)Jan 203 daysSathyanarayanan SriramChief Scientific OfficerSSale−1.08K$0.58−$627.56−38.2%1.75K after
Jan 23, 2023 (view filing)Jan 203 daysWilliams Douglas ESee RemarksSSale−5.08K$0.58−$2.94K−21.8%18.2K after
Jan 23, 2023 (view filing)Jan 203 daysHowze YalondaSee RemarksSSale−1.51K$0.58−$876.96−37.8%2.49K after
Jan 23, 2023 (view filing)Jan 203 daysBarna NicoleSee RemarksSSale−836$0.58−$484.88−9.3%8.11K after
Sep 16, 2022 (view filing)7:30 PM ETSep 151 dayAfeyan Noubar and 3 others10% OwnerPPurchase+933.3K––+365.2%1.19M after2 lots
Sep 16, 2022 (view filing)7:30 PM ETSep 151 dayAfeyan Noubar and 3 others10% OwnerPPurchase+933.3K–––210.7K afterDerivative2 lots
Sep 15, 2022 (view filing)6:53 PM ETSep 132 daysCrandell Keith and 6 others10% OwnerPPurchaseCommon Sotck+5.00M$1.50+$7.50M+129.7%8.85M after
Sep 15, 2022 (view filing)6:53 PM ETSep 132 daysCrandell Keith and 6 others10% OwnerPPurchase+5.00M–––5.00M afterDerivativeDuplicate filing
Sep 15, 2022 (view filing)Sep 132 daysGillis StevenDirectorPPurchase+5.00M––+199.7%7.50M after
Sep 15, 2022 (view filing)Sep 132 daysGillis StevenDirectorPPurchase+5.00M–––5.00M afterDerivative
Feb 7, 2022 (view filing)Jan 2018 daysLateBarna NicoleSee RemarksPPurchase+6.78K$7.37+$50.0KNew position6.78K after
Sep 28, 2021 (view filing)Jun 8112 daysLateSorensen BennySee RemarksSSale−8.53K$25.66−$219.0K−100.0%0 after2 lots
Sep 28, 2021 (view filing)Jun 8112 daysLateKonstantinov KonstantinChief Technology OfficerSSale−7.28K$25.60−$186.3K−100.0%0 after2 lots
Sep 28, 2021 (view filing)Aug 6-953 daysLateSathyanarayanan SriramChief Scientific OfficerSSale−2.60K$20.84−$54.2K−100.0%0 after3 lots